instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'TACROLIMUS'? | Rapid Improvement in Jaundice Using Transdermal Isosorbide Tape as a Nitric Oxide Donor in Two Adult Patients with Transplantation-associated Microangiopathy Related to Graft-versus-host Disease.
Two adult patients with acute leukemia developed transplantation-associated microangiopathy (TAM) related to graft-versus-ho... | UNK, TACROLIMUS WAS RE-INITIATED | DrugDosageText | CC BY-NC-ND | 34565772 | 21,025,087 | 2021-09-25 |
What was the outcome of reaction 'Graft versus host disease in liver'? | Rapid Improvement in Jaundice Using Transdermal Isosorbide Tape as a Nitric Oxide Donor in Two Adult Patients with Transplantation-associated Microangiopathy Related to Graft-versus-host Disease.
Two adult patients with acute leukemia developed transplantation-associated microangiopathy (TAM) related to graft-versus-ho... | Recovered | ReactionOutcome | CC BY-NC-ND | 34565772 | 21,025,087 | 2021-09-25 |
What was the outcome of reaction 'Graft versus host disease in skin'? | Rapid Improvement in Jaundice Using Transdermal Isosorbide Tape as a Nitric Oxide Donor in Two Adult Patients with Transplantation-associated Microangiopathy Related to Graft-versus-host Disease.
Two adult patients with acute leukemia developed transplantation-associated microangiopathy (TAM) related to graft-versus-ho... | Recovered | ReactionOutcome | CC BY-NC-ND | 34565772 | 21,025,087 | 2021-09-25 |
What was the outcome of reaction 'Microangiopathy'? | Rapid Improvement in Jaundice Using Transdermal Isosorbide Tape as a Nitric Oxide Donor in Two Adult Patients with Transplantation-associated Microangiopathy Related to Graft-versus-host Disease.
Two adult patients with acute leukemia developed transplantation-associated microangiopathy (TAM) related to graft-versus-ho... | Recovered | ReactionOutcome | CC BY-NC-ND | 34565772 | 21,025,087 | 2021-09-25 |
What was the outcome of reaction 'Sepsis'? | Rapid Improvement in Jaundice Using Transdermal Isosorbide Tape as a Nitric Oxide Donor in Two Adult Patients with Transplantation-associated Microangiopathy Related to Graft-versus-host Disease.
Two adult patients with acute leukemia developed transplantation-associated microangiopathy (TAM) related to graft-versus-ho... | Fatal | ReactionOutcome | CC BY-NC-ND | 34565772 | 21,025,087 | 2021-09-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute coronary syndrome'. | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | ASPIRIN, CLOPIDOGREL BISULFATE, EVEROLIMUS, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34565779 | 20,153,440 | 2021-09-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | ASPIRIN, CLOPIDOGREL BISULFATE, EVEROLIMUS, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34565779 | 20,153,440 | 2021-09-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angiopathy'. | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | ASPIRIN, CLOPIDOGREL BISULFATE, EVEROLIMUS, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34565779 | 20,153,440 | 2021-09-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | ASPIRIN, CLOPIDOGREL BISULFATE, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34565779 | 20,128,173 | 2021-09-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | ASPIRIN, CLOPIDOGREL BISULFATE, EVEROLIMUS, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34565779 | 20,126,056 | 2021-09-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic function abnormal'. | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | ASPIRIN, CLOPIDOGREL BISULFATE, EVEROLIMUS, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34565779 | 20,126,056 | 2021-09-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Positive vessel remodelling'. | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | ASPIRIN, CLOPIDOGREL BISULFATE, EVEROLIMUS, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34565779 | 20,153,440 | 2021-09-25 |
What is the weight of the patient? | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | 56 kg. | Weight | CC BY-NC-ND | 34565779 | 20,126,056 | 2021-09-25 |
What was the dosage of drug 'EVEROLIMUS'? | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | DRUG-ELUTING STENT | DrugDosageText | CC BY-NC-ND | 34565779 | 20,126,056 | 2021-09-25 |
What was the outcome of reaction 'Acute coronary syndrome'? | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | Recovering | ReactionOutcome | CC BY-NC-ND | 34565779 | 20,153,440 | 2021-09-25 |
What was the outcome of reaction 'Acute myocardial infarction'? | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | Recovering | ReactionOutcome | CC BY-NC-ND | 34565779 | 20,153,440 | 2021-09-25 |
What was the outcome of reaction 'Angiopathy'? | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | Recovering | ReactionOutcome | CC BY-NC-ND | 34565779 | 20,153,440 | 2021-09-25 |
What was the outcome of reaction 'Disease recurrence'? | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | Recovering | ReactionOutcome | CC BY-NC-ND | 34565779 | 20,128,173 | 2021-09-25 |
What was the outcome of reaction 'Positive vessel remodelling'? | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | Recovering | ReactionOutcome | CC BY-NC-ND | 34565779 | 20,153,440 | 2021-09-25 |
What was the outcome of reaction 'Vascular stent thrombosis'? | Very Late Stent Thrombosis After Discontinuation of Antiplatelet Agents During Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining After Implantation of a Second-generation Drug-eluting Stent.
A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myo... | Recovering | ReactionOutcome | CC BY-NC-ND | 34565779 | 20,153,440 | 2021-09-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | A Peptide Meets a Radionuclide to Combat a Rare Tumor.
Background: Neuroendocrine carcinomas (NECs) are rare malignancies with limited treatment options beyond surgery. Peptide receptor radionuclide therapy (PRRT) is a process by which a somatostatin analog (octreotate) is combined with a chelator (DOTA) and a radionuc... | CAPECITABINE, LANREOTIDE, TEMOZOLOMIDE, TOPOTECAN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34566515 | 20,127,837 | 2021 |
What was the administration route of drug 'TEMOZOLOMIDE'? | A Peptide Meets a Radionuclide to Combat a Rare Tumor.
Background: Neuroendocrine carcinomas (NECs) are rare malignancies with limited treatment options beyond surgery. Peptide receptor radionuclide therapy (PRRT) is a process by which a somatostatin analog (octreotate) is combined with a chelator (DOTA) and a radionuc... | Oral | DrugAdministrationRoute | CC BY | 34566515 | 20,127,837 | 2021 |
What was the dosage of drug 'CAPECITABINE'? | A Peptide Meets a Radionuclide to Combat a Rare Tumor.
Background: Neuroendocrine carcinomas (NECs) are rare malignancies with limited treatment options beyond surgery. Peptide receptor radionuclide therapy (PRRT) is a process by which a somatostatin analog (octreotate) is combined with a chelator (DOTA) and a radionuc... | 750 MILLIGRAM/SQ. METER, TWICE DAILY ON DAYS 1 THROUGH 14 OF A 28-DAY CYCLE | DrugDosageText | CC BY | 34566515 | 20,127,837 | 2021 |
What was the dosage of drug 'TEMOZOLOMIDE'? | A Peptide Meets a Radionuclide to Combat a Rare Tumor.
Background: Neuroendocrine carcinomas (NECs) are rare malignancies with limited treatment options beyond surgery. Peptide receptor radionuclide therapy (PRRT) is a process by which a somatostatin analog (octreotate) is combined with a chelator (DOTA) and a radionuc... | 200 MILLIGRAM/SQ. METER, ON DAYS 10 THROUGH 14 OF A 28-DAY CYCLE | DrugDosageText | CC BY | 34566515 | 20,127,837 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depression'. | Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment.
Akathisia, which characterized by subjective restlessness and objective hyperactivity, is induced mostly by antipsychotics and antidepressants. Chronic akathisia is defi... | CLOMIPRAMINE, CLONAZEPAM, ESCITALOPRAM OXALATE, LEVOMEPROMAZINE, MIRTAZAPINE, PROPRANOLOL HYDROCHLORIDE, QUETIAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 34566725 | 20,042,365 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment.
Akathisia, which characterized by subjective restlessness and objective hyperactivity, is induced mostly by antipsychotics and antidepressants. Chronic akathisia is defi... | CLOMIPRAMINE, CLONAZEPAM, ESCITALOPRAM OXALATE, LEVOMEPROMAZINE, MIRTAZAPINE, PROPRANOLOL HYDROCHLORIDE, QUETIAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 34566725 | 20,042,365 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment.
Akathisia, which characterized by subjective restlessness and objective hyperactivity, is induced mostly by antipsychotics and antidepressants. Chronic akathisia is defi... | LEVOMEPROMAZINE, PROPRANOLOL HYDROCHLORIDE, QUETIAPINE | DrugsGivenReaction | CC BY | 34566725 | 19,949,792 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple-drug resistance'. | Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment.
Akathisia, which characterized by subjective restlessness and objective hyperactivity, is induced mostly by antipsychotics and antidepressants. Chronic akathisia is defi... | CLOMIPRAMINE, CLONAZEPAM, ESCITALOPRAM OXALATE, LEVOMEPROMAZINE, MIRTAZAPINE, PROPRANOLOL HYDROCHLORIDE, QUETIAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 34566725 | 20,042,365 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment.
Akathisia, which characterized by subjective restlessness and objective hyperactivity, is induced mostly by antipsychotics and antidepressants. Chronic akathisia is defi... | LEVOMEPROMAZINE, PROPRANOLOL HYDROCHLORIDE, QUETIAPINE | DrugsGivenReaction | CC BY | 34566725 | 19,949,792 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Restlessness'. | Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment.
Akathisia, which characterized by subjective restlessness and objective hyperactivity, is induced mostly by antipsychotics and antidepressants. Chronic akathisia is defi... | CLOMIPRAMINE, CLONAZEPAM, ESCITALOPRAM OXALATE, LEVOMEPROMAZINE, MIRTAZAPINE, PROPRANOLOL HYDROCHLORIDE, QUETIAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 34566725 | 20,042,365 | 2021 |
What was the administration route of drug 'PROPRANOLOL HYDROCHLORIDE'? | Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment.
Akathisia, which characterized by subjective restlessness and objective hyperactivity, is induced mostly by antipsychotics and antidepressants. Chronic akathisia is defi... | Oral | DrugAdministrationRoute | CC BY | 34566725 | 19,949,792 | 2021 |
What was the administration route of drug 'QUETIAPINE'? | Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment.
Akathisia, which characterized by subjective restlessness and objective hyperactivity, is induced mostly by antipsychotics and antidepressants. Chronic akathisia is defi... | Oral | DrugAdministrationRoute | CC BY | 34566725 | 19,949,792 | 2021 |
What was the outcome of reaction 'Disturbance in attention'? | Case Report: Changes in Regional Cerebral Blood Flow in Chronic Akathisia of a Depressed Patient Before and After Electroconvulsive Therapy Treatment.
Akathisia, which characterized by subjective restlessness and objective hyperactivity, is induced mostly by antipsychotics and antidepressants. Chronic akathisia is defi... | Recovered | ReactionOutcome | CC BY | 34566725 | 20,045,356 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Long-Term Clinical and Immunological Impact of Severe COVID-19 on a Living Kidney Transplant Recipient - A Case Report.
The long-term impact of COVID-19 on transplant recipients remains unknown. We describe the case of a 30-year-old male kidney transplant recipient from Wuhan, China that was treated for severe COVID-19... | CYCLOSPORINE, HUMAN IMMUNOGLOBULIN G, METHYLPREDNISOLONE, MYCOPHENOLIC ACID, OSELTAMIVIR, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34567007 | 20,185,429 | 2021 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Long-Term Clinical and Immunological Impact of Severe COVID-19 on a Living Kidney Transplant Recipient - A Case Report.
The long-term impact of COVID-19 on transplant recipients remains unknown. We describe the case of a 30-year-old male kidney transplant recipient from Wuhan, China that was treated for severe COVID-19... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34567007 | 20,185,429 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Long-Term Clinical and Immunological Impact of Severe COVID-19 on a Living Kidney Transplant Recipient - A Case Report.
The long-term impact of COVID-19 on transplant recipients remains unknown. We describe the case of a 30-year-old male kidney transplant recipient from Wuhan, China that was treated for severe COVID-19... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34567007 | 20,185,429 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Long-Term Clinical and Immunological Impact of Severe COVID-19 on a Living Kidney Transplant Recipient - A Case Report.
The long-term impact of COVID-19 on transplant recipients remains unknown. We describe the case of a 30-year-old male kidney transplant recipient from Wuhan, China that was treated for severe COVID-19... | Oral | DrugAdministrationRoute | CC BY | 34567007 | 20,185,429 | 2021 |
What was the dosage of drug 'TACROLIMUS'? | Long-Term Clinical and Immunological Impact of Severe COVID-19 on a Living Kidney Transplant Recipient - A Case Report.
The long-term impact of COVID-19 on transplant recipients remains unknown. We describe the case of a 30-year-old male kidney transplant recipient from Wuhan, China that was treated for severe COVID-19... | UNK, ADMINISTERED 5 MICROG/L. | DrugDosageText | CC BY | 34567007 | 20,185,429 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Candida infection'. | External iliac artery pseudoaneurysm following treatment for arterio-ureteral fistula using a balloon-expandable stent-graft: A case report.
Sepsis and bleeding can lead to life-threatening complications, such as stent-graft infection and pseudoaneurysm, after stent-graft implantation. An 83 year-old woman was admitted... | ASPIRIN, CEFTRIAXONE SODIUM, DAPTOMYCIN, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34567330 | 20,097,154 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | External iliac artery pseudoaneurysm following treatment for arterio-ureteral fistula using a balloon-expandable stent-graft: A case report.
Sepsis and bleeding can lead to life-threatening complications, such as stent-graft infection and pseudoaneurysm, after stent-graft implantation. An 83 year-old woman was admitted... | ASPIRIN, CEFTRIAXONE SODIUM, DAPTOMYCIN, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34567330 | 20,097,154 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular pseudoaneurysm'. | External iliac artery pseudoaneurysm following treatment for arterio-ureteral fistula using a balloon-expandable stent-graft: A case report.
Sepsis and bleeding can lead to life-threatening complications, such as stent-graft infection and pseudoaneurysm, after stent-graft implantation. An 83 year-old woman was admitted... | ASPIRIN, CEFTRIAXONE SODIUM, DAPTOMYCIN, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34567330 | 20,097,154 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular stent thrombosis'. | External iliac artery pseudoaneurysm following treatment for arterio-ureteral fistula using a balloon-expandable stent-graft: A case report.
Sepsis and bleeding can lead to life-threatening complications, such as stent-graft infection and pseudoaneurysm, after stent-graft implantation. An 83 year-old woman was admitted... | ASPIRIN, CEFTRIAXONE SODIUM, DAPTOMYCIN, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34567330 | 20,097,154 | 2021-11 |
What was the outcome of reaction 'Candida infection'? | External iliac artery pseudoaneurysm following treatment for arterio-ureteral fistula using a balloon-expandable stent-graft: A case report.
Sepsis and bleeding can lead to life-threatening complications, such as stent-graft infection and pseudoaneurysm, after stent-graft implantation. An 83 year-old woman was admitted... | Recovered | ReactionOutcome | CC BY-NC-ND | 34567330 | 20,097,154 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Atypical metastatic lung cancer of the right ventricle on FDG PET/CT.
Although primary cardiac tumours are extremely uncommon, secondary tumours or cardiac metastasis are not. We present a 68-year-old gentleman with squamous cell carcinoma of the right lower lobe with bony metastasis to the right clavicle who was treat... | CARBOPLATIN, PACLITAXEL, PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34567334 | 20,509,983 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Atypical metastatic lung cancer of the right ventricle on FDG PET/CT.
Although primary cardiac tumours are extremely uncommon, secondary tumours or cardiac metastasis are not. We present a 68-year-old gentleman with squamous cell carcinoma of the right lower lobe with bony metastasis to the right clavicle who was treat... | CARBOPLATIN, PACLITAXEL, PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34567334 | 20,481,333 | 2021-11 |
What was the dosage of drug 'CARBOPLATIN'? | Atypical metastatic lung cancer of the right ventricle on FDG PET/CT.
Although primary cardiac tumours are extremely uncommon, secondary tumours or cardiac metastasis are not. We present a 68-year-old gentleman with squamous cell carcinoma of the right lower lobe with bony metastasis to the right clavicle who was treat... | UNK, CYCLE, 4 CYCLES | DrugDosageText | CC BY-NC-ND | 34567334 | 20,481,333 | 2021-11 |
What was the dosage of drug 'PACLITAXEL'? | Atypical metastatic lung cancer of the right ventricle on FDG PET/CT.
Although primary cardiac tumours are extremely uncommon, secondary tumours or cardiac metastasis are not. We present a 68-year-old gentleman with squamous cell carcinoma of the right lower lobe with bony metastasis to the right clavicle who was treat... | UNK, CYCLE, 4 CYCLES | DrugDosageText | CC BY-NC-ND | 34567334 | 20,481,333 | 2021-11 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Atypical metastatic lung cancer of the right ventricle on FDG PET/CT.
Although primary cardiac tumours are extremely uncommon, secondary tumours or cardiac metastasis are not. We present a 68-year-old gentleman with squamous cell carcinoma of the right lower lobe with bony metastasis to the right clavicle who was treat... | UNK, CYCLE, 4 CYCLES | DrugDosageText | CC BY-NC-ND | 34567334 | 20,481,333 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema'. | Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report.
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single ... | METHOTREXATE | DrugsGivenReaction | CC BY | 34567344 | 18,962,210 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report.
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single ... | METHOTREXATE | DrugsGivenReaction | CC BY | 34567344 | 18,962,210 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoglobin decreased'. | Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report.
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single ... | METHOTREXATE | DrugsGivenReaction | CC BY | 34567344 | 18,962,210 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report.
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single ... | METHOTREXATE | DrugsGivenReaction | CC BY | 34567344 | 18,962,210 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal inflammation'. | Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report.
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single ... | METHOTREXATE | DrugsGivenReaction | CC BY | 34567344 | 18,962,210 | 2021 |
What was the administration route of drug 'METHOTREXATE'? | Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report.
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single ... | Intramuscular | DrugAdministrationRoute | CC BY | 34567344 | 18,962,210 | 2021 |
What was the outcome of reaction 'Erythema'? | Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report.
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single ... | Recovered | ReactionOutcome | CC BY | 34567344 | 18,962,210 | 2021 |
What was the outcome of reaction 'Febrile neutropenia'? | Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report.
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single ... | Recovered | ReactionOutcome | CC BY | 34567344 | 18,962,210 | 2021 |
What was the outcome of reaction 'Haemoglobin decreased'? | Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report.
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single ... | Recovered | ReactionOutcome | CC BY | 34567344 | 18,962,210 | 2021 |
What was the outcome of reaction 'Mucosal inflammation'? | Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report.
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single ... | Recovered | ReactionOutcome | CC BY | 34567344 | 18,962,210 | 2021 |
What was the administration route of drug 'FUROSEMIDE'? | Fulminant cardiogenic shock due to cardiac sarcoidosis.
This case describes a 57-year-old man with unrecognized cardiac sarcoidosis who presented with progressive heart failure leading to cardiogenic shock. He required extracorporeal membrane oxygenation (ECMO) as a bridge to orthotopic heart transplantation. The case ... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 34567462 | 17,677,695 | 2021 |
What was the administration route of drug 'MILRINONE'? | Fulminant cardiogenic shock due to cardiac sarcoidosis.
This case describes a 57-year-old man with unrecognized cardiac sarcoidosis who presented with progressive heart failure leading to cardiogenic shock. He required extracorporeal membrane oxygenation (ECMO) as a bridge to orthotopic heart transplantation. The case ... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 34567462 | 17,677,695 | 2021 |
What was the administration route of drug 'NITROPRUSSIDE'? | Fulminant cardiogenic shock due to cardiac sarcoidosis.
This case describes a 57-year-old man with unrecognized cardiac sarcoidosis who presented with progressive heart failure leading to cardiogenic shock. He required extracorporeal membrane oxygenation (ECMO) as a bridge to orthotopic heart transplantation. The case ... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 34567462 | 17,677,695 | 2021 |
What was the dosage of drug 'FUROSEMIDE'? | Fulminant cardiogenic shock due to cardiac sarcoidosis.
This case describes a 57-year-old man with unrecognized cardiac sarcoidosis who presented with progressive heart failure leading to cardiogenic shock. He required extracorporeal membrane oxygenation (ECMO) as a bridge to orthotopic heart transplantation. The case ... | INFUSION | DrugDosageText | CC BY-NC | 34567462 | 17,675,128 | 2021 |
What was the dosage of drug 'MILRINONE'? | Fulminant cardiogenic shock due to cardiac sarcoidosis.
This case describes a 57-year-old man with unrecognized cardiac sarcoidosis who presented with progressive heart failure leading to cardiogenic shock. He required extracorporeal membrane oxygenation (ECMO) as a bridge to orthotopic heart transplantation. The case ... | INFUSION | DrugDosageText | CC BY-NC | 34567462 | 17,675,128 | 2021 |
What was the dosage of drug 'SODIUM NITROPRUSSIDE'? | Fulminant cardiogenic shock due to cardiac sarcoidosis.
This case describes a 57-year-old man with unrecognized cardiac sarcoidosis who presented with progressive heart failure leading to cardiogenic shock. He required extracorporeal membrane oxygenation (ECMO) as a bridge to orthotopic heart transplantation. The case ... | INFUSION | DrugDosageText | CC BY-NC | 34567462 | 17,675,128 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nosocomial infection'. | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34567547 | 20,326,656 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | AMIKACIN, ASCORBIC ACID, ASPIRIN, AZITHROMYCIN, CIPROFLOXACIN, DEXAMETHASONE, ENOXAPARIN, MYCOPHENOLATE MOFETIL, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TACROLIMUS, TOCILIZUMAB, VORICONAZOLE, ZINC | DrugsGivenReaction | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the dosage of drug 'AMIKACIN'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | 1.5 GRAM, QD | DrugDosageText | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the dosage of drug 'ASCORBIC ACID'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | 2 GRAM, QD | DrugDosageText | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the dosage of drug 'ASPIRIN'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | 160 MILLIGRAM, QD | DrugDosageText | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the dosage of drug 'CIPROFLOXACIN'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | 200 MILLIGRAM, BID | DrugDosageText | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the dosage of drug 'DEXAMETHASONE'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | 6 MILLIGRAM, QD | DrugDosageText | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the dosage of drug 'ENOXAPARIN'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | 0.6 INTERNATIONAL UNIT, BID | DrugDosageText | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the dosage of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | 4 GRAM, Q8H | DrugDosageText | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the dosage of drug 'TOCILIZUMAB'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | 400 MILLIGRAM, TWO DOSES WITHIN A 10 DAY INTERVAL | DrugDosageText | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the dosage of drug 'VORICONAZOLE'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | 200 MILLIGRAM, BID | DrugDosageText | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the dosage of drug 'ZINC'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | 45 MILLIGRAM, QD | DrugDosageText | CC BY | 34567547 | 20,321,671 | 2021-11 |
What was the outcome of reaction 'Acute kidney injury'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | Fatal | ReactionOutcome | CC BY | 34567547 | 20,326,656 | 2021-11 |
What was the outcome of reaction 'Acute respiratory distress syndrome'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | Fatal | ReactionOutcome | CC BY | 34567547 | 20,326,656 | 2021-11 |
What was the outcome of reaction 'COVID-19'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | Fatal | ReactionOutcome | CC BY | 34567547 | 20,326,656 | 2021-11 |
What was the outcome of reaction 'Disseminated intravascular coagulation'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | Fatal | ReactionOutcome | CC BY | 34567547 | 20,326,656 | 2021-11 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | Fatal | ReactionOutcome | CC BY | 34567547 | 20,326,656 | 2021-11 |
What was the outcome of reaction 'Septic shock'? | Management of post cardiac transplantation immunosuppression and COVID-19: A case report.
There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.
We report the case of a 60-year-old male, heart transplant... | Fatal | ReactionOutcome | CC BY | 34567547 | 20,326,656 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report.
Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute-phase treatment for venous thromboembolism complicated with severe immune th... | PREDNISOLONE | DrugsGivenReaction | CC BY | 34567553 | 20,041,704 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deep vein thrombosis'. | A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report.
Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute-phase treatment for venous thromboembolism complicated with severe immune th... | PREDNISOLONE | DrugsGivenReaction | CC BY | 34567553 | 20,041,704 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report.
Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute-phase treatment for venous thromboembolism complicated with severe immune th... | PREDNISOLONE | DrugsGivenReaction | CC BY | 34567553 | 20,041,704 | 2021-09 |
What was the administration route of drug 'PREDNISOLONE'? | A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report.
Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute-phase treatment for venous thromboembolism complicated with severe immune th... | Oral | DrugAdministrationRoute | CC BY | 34567553 | 20,041,704 | 2021-09 |
What was the outcome of reaction 'Condition aggravated'? | A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report.
Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute-phase treatment for venous thromboembolism complicated with severe immune th... | Recovered | ReactionOutcome | CC BY | 34567553 | 20,041,704 | 2021-09 |
What was the outcome of reaction 'Deep vein thrombosis'? | A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report.
Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute-phase treatment for venous thromboembolism complicated with severe immune th... | Recovered | ReactionOutcome | CC BY | 34567553 | 20,041,704 | 2021-09 |
What was the outcome of reaction 'Pulmonary embolism'? | A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report.
Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute-phase treatment for venous thromboembolism complicated with severe immune th... | Recovered | ReactionOutcome | CC BY | 34567553 | 20,041,704 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoglycaemia'. | Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail.
This case report demonstrates that using a non-approved long-acting GLP-1-RA (dulaglutide) in adolescents with T2D is possible and feasible under special circumstances when a... | INSULIN GLARGINE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34567554 | 20,130,462 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail.
This case report demonstrates that using a non-approved long-acting GLP-1-RA (dulaglutide) in adolescents with T2D is possible and feasible under special circumstances when a... | INSULIN GLARGINE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34567554 | 20,130,462 | 2021-09 |
What is the weight of the patient? | Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail.
This case report demonstrates that using a non-approved long-acting GLP-1-RA (dulaglutide) in adolescents with T2D is possible and feasible under special circumstances when a... | 78 kg. | Weight | CC BY-NC-ND | 34567554 | 20,130,462 | 2021-09 |
What was the outcome of reaction 'Hypoglycaemia'? | Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail.
This case report demonstrates that using a non-approved long-acting GLP-1-RA (dulaglutide) in adolescents with T2D is possible and feasible under special circumstances when a... | Recovered | ReactionOutcome | CC BY-NC-ND | 34567554 | 20,130,462 | 2021-09 |
What was the outcome of reaction 'Overdose'? | Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail.
This case report demonstrates that using a non-approved long-acting GLP-1-RA (dulaglutide) in adolescents with T2D is possible and feasible under special circumstances when a... | Recovered | ReactionOutcome | CC BY-NC-ND | 34567554 | 20,130,462 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A novel KCNT1 mutation in a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy.
We describe a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy (ADNFLE) and psychiatric problems in whom whole-exome family trio sequencing identified a heterozygous mutation in the po... | FENOFIBRATE, LEVETIRACETAM, OXCARBAZEPINE, VALPROIC ACID | DrugsGivenReaction | CC BY | 34567798 | 20,775,401 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A novel KCNT1 mutation in a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy.
We describe a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy (ADNFLE) and psychiatric problems in whom whole-exome family trio sequencing identified a heterozygous mutation in the po... | FENOFIBRATE, LEVETIRACETAM, OXCARBAZEPINE, VALPROIC ACID | DrugsGivenReaction | CC BY | 34567798 | 20,775,401 | 2021-01-01 |
What was the dosage of drug 'LEVETIRACETAM'? | A novel KCNT1 mutation in a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy.
We describe a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy (ADNFLE) and psychiatric problems in whom whole-exome family trio sequencing identified a heterozygous mutation in the po... | 1000 MG, QD | DrugDosageText | CC BY | 34567798 | 20,775,401 | 2021-01-01 |
What was the dosage of drug 'OXCARBAZEPINE'? | A novel KCNT1 mutation in a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy.
We describe a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy (ADNFLE) and psychiatric problems in whom whole-exome family trio sequencing identified a heterozygous mutation in the po... | 1800 MG, QD | DrugDosageText | CC BY | 34567798 | 20,775,401 | 2021-01-01 |
What was the dosage of drug 'VALPROIC ACID'? | A novel KCNT1 mutation in a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy.
We describe a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy (ADNFLE) and psychiatric problems in whom whole-exome family trio sequencing identified a heterozygous mutation in the po... | 2000 MG, QD | DrugDosageText | CC BY | 34567798 | 20,775,401 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary retention'. | COVID-19 associated pancreatitis: A mini case-series.
One of the recognized causes of acute pancreatitis is viral-induced pancreatitis. The SARS-COV-2 virus has been linked to pancreatic injury and hence the causation of acute pancreatitis. This paper reports three cases of acute pancreatitis linked to COVID-19 infecti... | ATORVASTATIN CALCIUM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY-NC-ND | 34567954 | 20,136,411 | 2021-10 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.